Overview

Global Radiotherapy Market Introduction
The global radiotherapy market is forecasted to value over USD 7 billion by 2026 end and register a CAGR of over 4% from the forecast period 2019-2026.
Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market. 

Global Radiotherapy Market Overview
The market is classified into product type, type, application, end-user, and region. In terms of type, the market is segmented into radiotherapy, internal beam radiotherapy, systemic radiotherapy, and external beam radiotherapy. External beam radiotherapy is expected to achieve high growth owing to the latest advancements in particle beam therapy. Growing research activities related to the field of radiation oncology is expected to propel the market.

Based on product type, external beam radiotherapy is expected to achieve the highest growth owing to the affordable cost of equipment of linear accelerator. The 360-degree radiation treatment offered by tomotherapy is adding further growth opportunities thus spurring the market.

Based on application, the prostate cancer segment of external beam radiotherapy market holds a vast share of the market. The rising cases of prostate cancer coupled with high success rates of external beam radiotherapy are expected to escalate the market. Moreover, the minimum long term risks associated with external beam radiotherapy is expected to positively influence the market.

On the basis of end-user, hospital segment is expected to hold the major market share. Rising healthcare infrastructure and easy access and availability of advanced equipment have expanded the market. The rising cases of cancer globally has resulted in more deployment of hospitals, thus accelerating the market growth. 

Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market. 

 Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region.  

Major players of the market are Hitachi Ltd., IsoRay Medical, Inc, Ion Beam Applications SA, Provision Healthcare, Varian Medical Systems, Inc, Mevion Medical Systems, Inc, Panacea Medical Technologies Pvt.Ltd, Accuray Incorporated and Elekta AB. 

Competitive Landscape: 
●     Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil
●     Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans
●     Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi
 

Global Radiotherapy Market Segmentation 
By Product Type 

●    External Beam Radiotherapy 
▪      Linear Accelerators
▪      Particle Therapy System
▪      Conventional Cobalt-60 Teletherapy Units                 
                    
●    Internal Beam Radiotherapy/Brachytherapy 
▪      Seeds
▪      Applicators
▪      Afterloaders
▪      Electronic Brachytherapy Products
                    
●    Systemic Radiotherapy 
▪      Iobenguane (I-131)
▪      Samarium-153
▪      Rhenium-186
                     

By Type 
●    External Beam Radiotherapy 
▪      Image-Guided Radiotherapy
▪      3d Conformal Radiotherapy
▪      Intensity-Modulated Radiotherapy
▪      Stereotactic Therapy
▪      Particle Therapy
                             
●    Internal Beam Radiotherapy 
▪      Low-Dose-Rate Brachytherapy      
▪      High-Dose-Rate Brachytherapy                 
▪      Pulsed-Dose-Rate Brachytherapy
                    
●    Systemic Radiotherapy 
▪      Intravenous Radiotherapy  
▪      Oral Radiotherapy
▪      Instillation Radiotherapy
                    

By Application 
●    External Beam Radiation Therapy
▪      Prostate Cancer
▪      Breast Cancer
▪      Lung Cancer
▪      Head and Neck Cancer
▪      Colorectal Cancer
▪      Other Cancers
 
●    Internal Beam Radiotherapy/Brachytherapy 
▪      Prostate Cancer
▪      Gynecological Cancer
▪      Breast Cancer
▪      Cervical Cancer
▪      Penile Cancer
▪      Other Cancers
 

 By End User 
●     Hospital        
●     Independent Radiotherapy Centers
                    

By Region: 
●     North America
●     Europe
●     Asia Pacific
●     Latin America
●     Rest of the World

 

FutureWise Key Takeaways
●  Growth Prospects
●  SWOT Analysis
●  Key Trends
●  Key data-points affecting market growth
 

Objectives of the Study:
• To provide with an exhaustive analysis on the global radiotherapy market by type, by product type, by application, by end-user and by region 
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 970 279 4295

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics